-
1
-
-
0000995321
-
Glycogen storage disease type II: Acid a-glucosidase (acid maltase) deficiency
-
Scriver CR, Beaudet AL, Sly WS, Valle D (eds) McGraw-Hill: New York
-
Hirschhorn R, Reuser AJJ. Glycogen storage disease type II: acid a-glucosidase (acid maltase) deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic and Molecular Basis for Inherited Disease. McGraw-Hill: New York, 2001, pp 3389-3420.
-
(2001)
The Metabolic and Molecular Basis for Inherited Disease
, pp. 3389-3420
-
-
Hirschhorn, R.1
Ajj, R.2
-
3
-
-
0027392113
-
Structural and functional-changes of lysosomal acid alpha-glucosidase during intracellular-transport and maturation
-
Wisselaar HA, Kroos MA, Hermans MMP, Vanbeeumen J, Reuser AJJ. Structural and functional-changes of lysosomal acid alpha-glucosidase during intracellular-transport and maturation. J Biol Chem 1993; 268: 2223-2231.
-
(1993)
J Biol Chem
, vol.268
, pp. 2223-2231
-
-
Wisselaar, H.A.1
Kroos, M.A.2
Mmp, H.3
Vanbeeumen, J.4
Ajj, R.5
-
4
-
-
0032698194
-
Human acid alpha-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II
-
Bijvoet AG, Van Hirtum H, Kroos MA, Van de Kamp EH, Schoneveld O, Visser P et al. Human acid alpha-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II. Hum Mol Genet 1999; 8: 2145-2153.
-
(1999)
Hum Mol Genet
, vol.8
, pp. 2145-2153
-
-
Bijvoet, A.G.1
Van Hirtum, H.2
Kroos, M.A.3
Van De Kamp, E.H.4
Schoneveld, O.5
Visser, P.6
-
5
-
-
0142089744
-
Enzyme replacement therapy in the mouse model of Pompe disease
-
Raben N, Danon M, Gilbert AL, Dwivedi S, Collins B, Thurberg BL et al. Enzyme replacement therapy in the mouse model of Pompe disease. Mol Genet Metab 2003; 80: 159-169.
-
(2003)
Mol Genet Metab
, vol.80
, pp. 159-169
-
-
Raben, N.1
Danon, M.2
Gilbert, A.L.3
Dwivedi, S.4
Collins, B.5
Thurberg, B.L.6
-
6
-
-
0035746540
-
Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trial
-
Amalfitano A, Bengur AR, Morse RP, Majure JM, Case LE, Veerling DL et al. Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med 2001; 3: 132-138.
-
(2001)
Genet Med
, vol.3
, pp. 132-138
-
-
Amalfitano, A.1
Bengur, A.R.2
Morse, R.P.3
Majure, J.M.4
Case, L.E.5
Veerling, D.L.6
-
7
-
-
2942570942
-
Long term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk
-
Van den Hout JMP, Kamphoven JHJ, Winkel LPF, Arts WFM, De Klerk JBC, Loonen MCB et al. Long term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics 2004; 113: E448-E457.
-
(2004)
Pediatrics
, vol.113
-
-
Van Den Hout Jmp1
Jhj, K.2
Lpf, W.3
Wfm, A.4
De Klerk Jbc5
McB, L.6
-
8
-
-
33846033132
-
Recombinant human acid {alpha}-glucosidase: Major clinical benefits in infantile-onset Pompe disease
-
Kishnani PS, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL et al. Recombinant human acid {alpha}-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 2007; 68: 99-109.
-
(2007)
Neurology
, vol.68
, pp. 99-109
-
-
Kishnani, P.S.1
Corzo, D.2
Nicolino, M.3
Byrne, B.4
Mandel, H.5
Hwu, W.L.6
-
9
-
-
71649099089
-
Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants
-
Kishnani PS, Goldenberg PC, Dearmey SL, Heller J, Benjamin D, Young S et al. Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. Mol Genet Metab 2010; 99: 26-36.
-
(2010)
Mol Genet Metab
, vol.99
, pp. 26-36
-
-
Kishnani, P.S.1
Goldenberg, P.C.2
Dearmey, S.L.3
Heller, J.4
Benjamin, D.5
Young, S.6
-
10
-
-
27744533046
-
Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II
-
Franco LM, Sun B, Yang X, Bird A, Zhang H, Schneider A et al. Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II. Mol Ther 2005; 12: 876-884.
-
(2005)
Mol Ther
, vol.12
, pp. 876-884
-
-
Franco, L.M.1
Sun, B.2
Yang, X.3
Bird, A.4
Zhang, H.5
Schneider, A.6
-
11
-
-
46249131028
-
Ability of adeno-associated virus serotype 8-mediated hepatic expression of acid alpha-glucosidase to correct the biochemical and motor function deficits of presymptomatic and symptomatic Pompe mice
-
Ziegler RJ, Bercury SD, Fidler J, Zhao MA, Foley J, Taksir TVet al. Ability of adeno-associated virus serotype 8-mediated hepatic expression of acid alpha-glucosidase to correct the biochemical and motor function deficits of presymptomatic and symptomatic Pompe mice. Hum Gene Ther 2008; 19: 609-621.
-
(2008)
Hum Gene Ther
, vol.19
, pp. 609-621
-
-
Ziegler, R.J.1
Bercury, S.D.2
Fidler, J.3
Zhao, M.A.4
Foley, J.5
Taksir, T.V.6
-
12
-
-
33750995541
-
Enhanced efficacy of an AAV vector encoding chimeric, highly secreted acid alpha-glucosidase in glycogen storage disease type II
-
Sun B, Zhang H, Benjamin Jr DK, Brown T, Bird A, Young SP et al. Enhanced efficacy of an AAV vector encoding chimeric, highly secreted acid alpha-glucosidase in glycogen storage disease type II. Mol Ther 2006; 14: 822-830.
-
(2006)
Mol Ther
, vol.14
, pp. 822-830
-
-
Sun, B.1
Zhang, H.2
Benjamin Jr., D.K.3
Brown, T.4
Bird, A.5
Young, S.P.6
-
13
-
-
19444362297
-
Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter
-
Sun B, Zhang H, Franco LM, Brown T, Bird A, Schneider A et al. Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter. Mol Ther 2005; 11: 889-898.
-
(2005)
Mol Ther
, vol.11
, pp. 889-898
-
-
Sun, B.1
Zhang, H.2
Franco, L.M.3
Brown, T.4
Bird, A.5
Schneider, A.6
-
14
-
-
48349114962
-
Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy
-
Sun B, Young SP, Li P, Di C, Brown T, Salva MZ et al. Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy. Mol Ther 2008; 16: 1366-1371.
-
(2008)
Mol Ther
, vol.16
, pp. 1366-1371
-
-
Sun, B.1
Young, S.P.2
Li, P.3
Di Brown C, T.4
Salva, M.Z.5
-
15
-
-
4043092073
-
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
-
Gregorevic P, Blankinship MJ, Allen JM, Crawford RW, Meuse L, Miller DG et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 2004; 10: 828-834.
-
(2004)
Nat Med
, vol.10
, pp. 828-834
-
-
Gregorevic, P.1
Blankinship, M.J.2
Allen, J.M.3
Crawford, R.W.4
Meuse, L.5
Miller, D.G.6
-
16
-
-
33644820684
-
Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
-
Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ et al. Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response. Nat Med 2006; 12: 342-347.
-
(2006)
Nat Med
, vol.12
, pp. 342-347
-
-
Manno, C.S.1
Pierce, G.F.2
Arruda, V.R.3
Glader, B.4
Ragni, M.5
Rasko, J.J.6
-
17
-
-
4344715026
-
A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs
-
Hagstrom JE, Hegge J, Zhang G, Noble M, Budker V, Lewis DL et al. A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. Mol Ther 2004; 10: 386-398.
-
(2004)
Mol Ther
, vol.10
, pp. 386-398
-
-
Hagstrom, J.E.1
Hegge, J.2
Zhang, G.3
Noble, M.4
Budker, V.5
Lewis, D.L.6
-
18
-
-
25444456371
-
Uniform scale-independent gene transfer to striated muscle after transvenular extravasation of vector
-
Su LT, Gopal K, Wang Z, Yin X, Nelson A, Kozyak BW et al. Uniform scale-independent gene transfer to striated muscle after transvenular extravasation of vector. Circulation 2005; 112: 1780-1788.
-
(2005)
Circulation
, vol.112
, pp. 1780-1788
-
-
Su, L.T.1
Gopal, K.2
Wang, Z.3
Yin, X.4
Nelson, A.5
Kozyak, B.W.6
-
19
-
-
58849124144
-
Hydrodynamic limb vein injection of AAV8 canine myostatin propeptide gene in normal dogs enhances muscle growth
-
Qiao C, Li J, Zheng H, Bogan J, Li J, Yuan Z et al. Hydrodynamic limb vein injection of AAV8 canine myostatin propeptide gene in normal dogs enhances muscle growth. Hum Gene Ther 2009; 20: 1-10.
-
(2009)
Hum Gene Ther
, vol.20
, pp. 1-10
-
-
Qiao, C.1
Li, J.2
Zheng, H.3
Bogan, J.4
Li, J.5
Yuan, Z.6
-
20
-
-
33846300685
-
Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle
-
Salva MZ, Himeda CL, Tai PW, Nishiuchi E, Gregorevic P, Allen JM et al. Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle. Mol Ther 2007; 15: 320-329.
-
(2007)
Mol Ther
, vol.15
, pp. 320-329
-
-
Salva, M.Z.1
Himeda, C.L.2
Tai, P.W.3
Nishiuchi, E.4
Gregorevic, P.5
Allen, J.M.6
-
21
-
-
68249119765
-
Evaluation of vascular delivery methodologies to enhance rAAV6-mediated gene transfer to canine striated musculature
-
Gregorevic P, Schultz BR, Allen JM, Halldorson JB, Blankinship MJ, Meznarich NA et al. Evaluation of vascular delivery methodologies to enhance rAAV6-mediated gene transfer to canine striated musculature. Mol Ther 2009; 17: 1427-1433.
-
(2009)
Mol Ther
, vol.17
, pp. 1427-1433
-
-
Gregorevic, P.1
Schultz, B.R.2
Allen, J.M.3
Halldorson, J.B.4
Blankinship, M.J.5
Meznarich, N.A.6
-
22
-
-
28844475009
-
Rapid intravascular injection into limb skeletal muscle: A damage assessment study
-
Toumi H, Hegge J, Subbotin V, Noble M, Herweijer H, Best TM et al. Rapid intravascular injection into limb skeletal muscle: a damage assessment study. Mol Ther 2006; 13: 229-236.
-
(2006)
Mol Ther
, vol.13
, pp. 229-236
-
-
Toumi, H.1
Hegge, J.2
Subbotin, V.3
Noble, M.4
Herweijer, H.5
Best, T.M.6
-
23
-
-
34247235162
-
Magnetic resonance imaging-monitored plasmid DNA delivery in primate limb muscle
-
Vigen KK, Hegge JO, Zhang G, Mukherjee R, Braun S, Grist TM et al. Magnetic resonance imaging-monitored plasmid DNA delivery in primate limb muscle. Hum Gene Ther 2007; 18: 257-268.
-
(2007)
Hum Gene Ther
, vol.18
, pp. 257-268
-
-
Vigen, K.K.1
Hegge, J.O.2
Zhang, G.3
Mukherjee, R.4
Braun, S.5
Grist, T.M.6
-
24
-
-
77957935853
-
Evaluation of hydrodynamic limb vein injections in non-human primates
-
Hegge JO, Wooddell CI, Zhang G, Hagstrom JE, Braun S, Huss T et al. Evaluation of hydrodynamic limb vein injections in non-human primates. Hum Gene Ther 2010; 21: 829-842.
-
(2010)
Hum Gene Ther
, vol.21
, pp. 829-842
-
-
Hegge, J.O.1
Wooddell, C.I.2
Zhang, G.3
Hagstrom, J.E.4
Braun, S.5
Huss, T.6
-
25
-
-
33748413905
-
Autophagy and lysosomes in Pompe disease
-
Fukuda T, Roberts A, Ahearn M, Zaal K, Ralston E, Plotz PH et al. Autophagy and lysosomes in Pompe disease. Autophagy 2006; 2: 318-320.
-
(2006)
Autophagy
, vol.2
, pp. 318-320
-
-
Fukuda, T.1
Roberts, A.2
Ahearn, M.3
Zaal, K.4
Ralston, E.5
Plotz, P.H.6
-
26
-
-
0024534981
-
Effect of hind-limb suspension on young and adult skeletal muscle
-
Haida N, Fowler Jr WM, Abresch RT, Larson DB, Sharman RB, Taylor RG et al. Effect of hind-limb suspension on young and adult skeletal muscle. I. Normal mice. Exp Neurol 1989; 103: 68-76.
-
(1989)
I. Normal Mice. Exp Neurol
, vol.103
, pp. 68-76
-
-
Haida, N.1
Fowler Jr., W.M.2
Abresch, R.T.3
Larson, D.B.4
Sharman, R.B.5
Taylor, R.G.6
-
27
-
-
0036866888
-
Differentiating idiopathic inflammatory myopathies from metabolic myopathies
-
Wortmann RL, DiMauro S. Differentiating idiopathic inflammatory myopathies from metabolic myopathies. Rheum Dis Clin N Am 2002; 28: 759-778.
-
(2002)
Rheum Dis Clin N Am
, vol.28
, pp. 759-778
-
-
Wortmann, R.L.1
Dimauro, S.2
-
28
-
-
0037015049
-
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
-
Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 11854-11859.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 11854-11859
-
-
Gao, G.P.1
Alvira, M.R.2
Wang, L.3
Calcedo, R.4
Johnston, J.5
Wilson, J.M.6
-
29
-
-
14444274334
-
Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II
-
Raben N, Nagaraju K, Lee E, Kessler P, Byrne B, Lee L et al. Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J Biol Chem 1998; 273: 19086-19092.
-
(1998)
J Biol Chem
, vol.273
, pp. 19086-19092
-
-
Raben, N.1
Nagaraju, K.2
Lee, E.3
Kessler, P.4
Byrne, B.5
Lee, L.6
-
30
-
-
0033529902
-
Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase
-
Amalfitano A, McVie-Wylie AJ, Hu H, Dawson TL, Raben N, Plotz P et al. Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. Proc Natl Acad Sci USA 1999; 96: 8861-8866.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 8861-8866
-
-
Amalfitano, A.1
McVie-Wylie, A.J.2
Hu, H.3
Dawson, T.L.4
Raben, N.5
Plotz, P.6
-
31
-
-
10944239670
-
Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II
-
Sun B, Zhang H, Franco LM, Young SP, Schneider A, Bird A et al. Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II. Mol Ther 2005; 11: 57-65.
-
(2005)
Mol Ther
, vol.11
, pp. 57-65
-
-
Sun, B.1
Zhang, H.2
Franco, L.M.3
Young, S.P.4
Schneider, A.5
Bird, A.6
|